Cargando…
Upregulation of Cysteine Protease Cathepsin X in the 6-Hydroxydopamine Model of Parkinson’s Disease
Parkinson’s disease (PD) is a neurodegenerative disorder characterized by loss of midbrain dopaminergic neurons in the substantia nigra pars compacta (SNc). In vitro, a contribution to neuroinflammation and neurotoxicity has been shown for the lysosomal protease cathepsin X; however, its expression...
Autores principales: | Pišlar, Anja, Tratnjek, Larisa, Glavan, Gordana, Živin, Marko, Kos, Janko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6225071/ https://www.ncbi.nlm.nih.gov/pubmed/30450037 http://dx.doi.org/10.3389/fnmol.2018.00412 |
Ejemplares similares
-
Neuroinflammation-Induced Upregulation of Glial Cathepsin X Expression and Activity in vivo
por: Pišlar, Anja, et al.
Publicado: (2020) -
New Insights into the Role of Cysteine Cathepsins in Neuroinflammation
por: Pišlar, Anja, et al.
Publicado: (2021) -
Cysteine Cathepsins in Tumor-Associated Immune Cells
por: Jakoš, Tanja, et al.
Publicado: (2019) -
Up-regulation of Synaptotagmin IV within amyloid plaque-associated dystrophic neurons in Tg2576 mouse model of Alzheimer’s disease
por: Tratnjek, Larisa, et al.
Publicado: (2013) -
Cysteine Peptidase Cathepsin X as a Therapeutic Target for Simultaneous TLR3/4-mediated Microglia Activation
por: Pišlar, Anja, et al.
Publicado: (2022)